explore -WSS

explore

author：comprehensive 2025-09-06 01:55:35 - browse：89

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Flagship Pioneering startup Sonata Therapeutics lays off 21

hotspot

WSS

WATCH: Why do our ears pop?

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

FDA warns medical device makers about rise in fabricated data

Telehealth startups turn to complex chronic diseases

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

MD Anderson's Padmanee Sharma responds to research credit suit

hotspot

explore

entertainment

Peter Hotez and the public health issue of online harassment

Surprise medical billing ban raises prices elsewhere

In age of alternative facts, a scholarly course on calling out crap

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Medicare proposal to cover medical devices draws a mixed reaction

Medicare Advantage enrollment grows 7.1% to 33.4 million people

ChatGPT in medicine: STAT answers readers' burning questions

Use wet bulb globe temperature, not heat index, to protect workers

In Memoriam: Notable people who died in 2023

Researchers on aging grapple with how to calculate biological age

entertainment

Bird flu outbreak in cows is latest avian flu curveball

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Sanofi strikes deal with Novavax, boosting the vaccine maker

Obamacare plans could cover weight loss drugs

Dairy farmers resist CDC push for PPE against bird flu virus

How to improve immunocompromised access to mAb treatments

hotspot

hotspot

focus

explore